elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q34487189-10C2CC21-3DF1-427F-8FA9-A33F7AF4A82F
Q34487189-10C2CC21-3DF1-427F-8FA9-A33F7AF4A82F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34487189-10C2CC21-3DF1-427F-8FA9-A33F7AF4A82F
Generation of knock-in primary human T cells using Cas9 ribonucleoproteins.
P2860
Q34487189-10C2CC21-3DF1-427F-8FA9-A33F7AF4A82F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34487189-10C2CC21-3DF1-427F-8FA9-A33F7AF4A82F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
f643fb159d4ca678f616b51185bb927fecf5e7cd
P2860
Anti-PD-1 antibody therapy potently enhances the eradication of established tumors by gene-modified T cells.